Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

17.55
Delayed Data
As of Sep 25
 +0.40 / +2.33%
Today’s Change
10.75
Today|||52-Week Range
19.90
+16.61%
Year-to-Date

Today’s Trading

Previous close17.15
Today’s open17.05
Day’s range17.05 - 17.65
Volume691,290
Average volume (3 months)677,654
Market cap$1.3B
Dividend yield--
Data as of 09/25/2017

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-346.81%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...-0.25-1.82%
XLRNAcceleron Pharma Inc+0.09+0.26%
NDRMNeuroderm Ltd-0.02-0.06%
EPZMEpizyme Inc-0.45-2.65%
Data as of 09/25/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer, Treasurer &
Senior VP
Scott M. Storer
Corporate headquarters
Cambridge, Massachusetts

Forecasts